CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −279 | $479.89 | $134K | 9,351 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −481 | $480.56 | $231K | 8,870 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −510 | $482.05 | $246K | 8,360 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,293 | $482.93 | $624K | 7,067 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,728 | $484.05 | $836K | 5,339 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,625 | $485.00 | $1.3M | 2,714 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −798 | $486.20 | $388K | 1,916 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,199 | $487.02 | $584K | 717 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −587 | $487.98 | $286K | 130 |
| 2026-03-05 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Options 10b5-1 | −9,500 | 202,000 | ||
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 45,144 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −368 | $479.43 | $176K | 44,776 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,602 | $480.22 | $769K | 43,174 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −720 | $481.33 | $347K | 42,454 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,177 | $482.68 | $568K | 41,277 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,086 | $483.54 | $525K | 40,191 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,398 | $484.55 | $677K | 38,793 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,006 | $485.32 | $488K | 37,787 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −743 | $486.52 | $361K | 37,044 |
| 2026-03-05 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $487.65 | $98K | 36,844 |
Page 153 of 171 · 3,408 trades